The development of metastatic disease in patients with paraganglioma is an unusual and challenging event. This case report and review describes the specific features of this disease and the multiple therapeutic options.
Alok Mohanty, MD
Advertisement
Articles by Alok Mohanty, MD
Advertisement
Latest Updated Articles
- Paraganglioma: A Potentially Challenging Tumor
Published: March 1st 2008 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
What Do Physicians and Patients Think About ADCs as Cancer Treatment?
5
